2. Academic Validation
  3. Ajugol's upregulation of TFEB-mediated autophagy alleviates endoplasmic reticulum stress in chondrocytes and retards osteoarthritis progression in a mouse model

Ajugol's upregulation of TFEB-mediated autophagy alleviates endoplasmic reticulum stress in chondrocytes and retards osteoarthritis progression in a mouse model

  • Chin Med. 2023 Sep 7;18(1):113. doi: 10.1186/s13020-023-00824-7.
Jingtao Wu 1 2 3,  Heng Yu 1 2 3,  Yangcan Jin 1 2 3,  Jingquan Wang 1 2 3,  Liwen Zhou 4,  Teng Cheng 1 2 3,  Zhao Zhang 1 2 3,  Binghao Lin 1 2 3,  Jiansen Miao 1 2 3,  Zhongke Lin 5 6 7
Affiliations

Affiliations

  • 1 Department of Orthopaedics, Wenzhou Key Laboratory of Perinatal Medicine, The Second Affiliated Hospital and Yuying Children's Hospital of Wenzhou Medical University, Wenzhou, 325000, Zhejiang Province, China.
  • 2 Key Laboratory of Orthopaedics of Zhejiang Province, Wenzhou, 325000, Zhejiang Province, China.
  • 3 The Second School of Medicine, Wenzhou Medical University, Wenzhou, 325000, Zhejiang Province, China.
  • 4 The First School of Medicine, Wenzhou Medical University, Wenzhou, 325000, Zhejiang Province, China.
  • 5 Department of Orthopaedics, Wenzhou Key Laboratory of Perinatal Medicine, The Second Affiliated Hospital and Yuying Children's Hospital of Wenzhou Medical University, Wenzhou, 325000, Zhejiang Province, China. [email protected].
  • 6 Key Laboratory of Orthopaedics of Zhejiang Province, Wenzhou, 325000, Zhejiang Province, China. [email protected].
  • 7 The Second School of Medicine, Wenzhou Medical University, Wenzhou, 325000, Zhejiang Province, China. [email protected].
PMID: 37679844 DOI: 10.1186/s13020-023-00824-7
Abstract

Background: Osteoarthritis (OA), a degenerative disease with a high global prevalence, is characterized by the degradation of the extracellular matrix (ECM) and the Apoptosis of chondrocytes. Ajugol, a extract derived from the herb Rehmannia glutinosa, has not yet been investigated for its potential in modulating the development of OA.

Methods: We employed techniques such as western blotting, immunofluorescence, immunohistochemistry, X-ray imaging, HE staining, and SO staining to provide biological evidence supporting the role of Ajugol as a potential therapeutic agent for modulating OA. Furthermore, in an in vivo experiment, intra-peritoneal injection of 50 mg/kg Ajugol effectively mitigated the progression of OA following destabilization of the medial meniscus (DMM) surgery.

Results: Our findings revealed that treatment with 50 μM Ajugol activated TFEB-mediated Autophagy, alleviating ER stress-induced chondrocyte Apoptosis and ECM degradation caused by TBHP. Furthermore, in an in vivo experiment, intra-peritoneal injection of 50 mg/kg Ajugol effectively mitigated the progression of OA following destabilization of the medial meniscus (DMM) surgery.

Conclusion: These results provide compelling biological evidence supporting the role of Ajugol as a potential therapeutic agent for modulating OA by activating Autophagy and attenuating ER stress-induced cell death and ECM degradation. The promising in vivo results further suggest the potential of Ajugol as a treatment strategy for OA progression.

Keywords

Ajugol; Autophagy; DMM; ER stress; Osteoarthritis; TBHP; TFEB.

Figures
Products